Treatment for Elevated Bilirubin Due to Hemolytic Causes
Diagnostic Evaluation
- The American Academy of Pediatrics recommends confirming hemolysis through laboratory tests including reticulocyte count, peripheral blood smear, haptoglobin, and lactate dehydrogenase (LDH) 3, 1
- Direct antiglobulin test (Coombs') is used to differentiate immune from non-immune causes 2
- End-tidal carbon monoxide (ETCOc) measurement provides direct assessment of heme catabolism rate and bilirubin production 1, 4
- Complete blood count with differential and smear for red cell morphology is also recommended 2
Treatment Algorithm
- The American Academy of Pediatrics recommends determining severity based on total serum bilirubin (TSB) level, rate of rise, and presence of risk factors 1, 2
- Calculate bilirubin/albumin (B/A) ratio to assess risk for neurotoxicity 1, 5
- For mild-moderate elevation, initiate intensive phototherapy immediately and ensure adequate hydration and nutrition 1, 2, 6
- For severe elevation (TSB ≥25 mg/dL or 428 μmol/L), consider it a medical emergency requiring immediate hospitalization and initiate intensive phototherapy without delay 2
- Prepare for possible exchange transfusion 1, 5
Exchange Transfusion
- Perform exchange transfusion if TSB remains above exchange levels after 6 hours of intensive phototherapy or if signs of acute bilirubin encephalopathy develop 1, 2, 5
- Exchange transfusion guidelines based on B/A ratio: consider when B/A ratio >8.0 for infants ≥38 weeks, >7.2 for infants 35-36 6/7 weeks with hemolysis, and >6.8 for infants 35-37 6/7 weeks with hemolysis 1, 5
Monitoring and Follow-up
- For infants receiving intensive phototherapy, feed every 2-3 hours to maintain hydration and repeat TSB within 2-3 hours if TSB ≥25 mg/dL 2
- Discontinue phototherapy when TSB falls below 13-14 mg/dL (239 μmol/L) 2